CSF1 and cancer: Compared with normal samples, the expression levels of SPP1 and CSF1 were higher in subgroup cancer samples, including subgrouping by gender, age, weight, race, stage, tumor grade, nodal metastasis status, and TP53 mutant status (Fig. S1).